Harvard Bioscience (HBIO) Operating Income Growth (5y) (2015 - 2026)
Harvard Bioscience (HBIO) Operating Income Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 129.26 Bn | 124.05 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 46.23 Bn | 45.42 Bn | 2.15 Bn |
| 3 | Alcon | 33.66 Bn | 32.00 Bn | 1.53 Bn |
| 4 | Medline | 33.07 Bn | 30.84 Bn | 1.84 Bn |
| 5 | Resmed | 30.36 Bn | 28.70 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 24.00 Bn | 23.56 Bn | 329.20 Mn |
| 7 | Solventum | 14.89 Bn | 14.33 Bn | 1.10 Bn |
| 8 | Cooper Companies | 13.96 Bn | 13.82 Bn | 735.40 Mn |
| 9 | Baxter International | 12.52 Bn | 10.51 Bn | 891.00 Mn |
| 10 | Harvard Bioscience | 27.13 Mn | 20.03 Mn | 12.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -37.48% |
| Dec 31, 2025 | -9.10% |
| Sep 30, 2025 | 1.60% |
| Jun 30, 2025 | -28.27% |
| Mar 31, 2025 | -72.28% |
| Dec 31, 2024 | -63.21% |
| Sep 30, 2024 | -6.54% |
| Jun 30, 2024 | -61.76% |
| Mar 31, 2024 | -80.18% |
| Dec 31, 2023 | -30.52% |
| Sep 30, 2023 | -24.97% |
| Jun 30, 2023 | 32.50% |
| Mar 31, 2023 | 27.59% |
| Dec 31, 2022 | -26.36% |
| Sep 30, 2022 | -57.35% |
| Jun 30, 2022 | 75.95% |
| Mar 31, 2022 | -80.53% |
| Dec 31, 2021 | 28.57% |
| Sep 30, 2021 | 21.74% |
| Jun 30, 2021 | 15.65% |